Stratevi

As the name Stratevi suggests, we seamlessly combine strategy & evidence. We partner with biotechnology, pharmaceutical and medical device companies to creatively develop and communicate evidence to drive value and ensure optimal access to therapy for patients. Services Include: -Value Proposition Development -Strategic Planning -Study Design Recommendations -Competitive Simulations -ICER Reviews -Real World Outcome Studies -Economic Models -Prevalence-Based Outcome Models -Retrospective Database Analyses -Value Dossiers & Publications -Brand Access Toolkits -Interactive Training Solutions -Posters & manuscripts

Heor,patient reported outcomes,hrqol,cost effectiveness,cost model,real world evidence,value communication,value proposition development,payers,icer,observational studies,comparative effectiveness research,rare and orphan disease,biotech,pharmaceutical,medical device,consultant,strategy consulting,hta,health technology assessment,health economics,and outcomes research

Stratevi operates in the Biotechnology research industry.

Stratevi's revenue is 11m - 100m

Stratevi has 11 - 50 employees.